Latest News
mSurvey has secured an investment from Safaricom's Spark Venture Fund, a USD1 million fund with an objective of accelerating high-potential Kenya-based mobile technology start-ups.
The investment in mSurvey marks the second and largest Spark Venture Fund investment to date.
With the investment, Safaricom Spark joins Silicon Valley's Cross Culture Ventures and the Virgin Group-backed, Caribbean-focused Alpha Angels network as investors in mSurvey.
Terms of the deal were not disclosed.
mSurvey will use the Spark Venture Fund investment to drive a value-add to merchants who use Safaricom's Lipa Na M-PESA service, a solution that allows consumers to pay
Early-stage venture capital firm True Ventures has raised USD310 million for its fifth fund, True Ventures V.
With the close of this fund, True now manages approximately USD1.3 billion in capital.
True received support from substantially all of its existing investor base and a few new institutional investors.
Celebrating its 10-year anniversary this year, True Ventures has enjoyed a consistent track record of success in multiple markets including connected hardware, enterprise software and infrastructure.
Successful investments include Fitbit (NYSE: FIT), MakerBot (acquired by Stratasys), Goodreads (acquired by Amazon), BrightRoll (acquired by Yahoo!), and Automattic (the company behind
Guardian Capital Partners has acquired Carson-Dellosa Publishing in partnership with the firm’s existing executive management team, which will continue operating the company going forward.
Headquartered in Greensboro, North Carolina, Carson-Dellosa is a provider of K-8 supplemental education content for parents, teachers and students with a portfolio of brands including Spectrum, Summer Bridge and Carson-Dellosa Education.
With 35 years of experience in the consumer educational products market, the company offers digital and print workbooks, test-prep, hands-on learning materials and classroom décor and resources.
Carson-Dellosa’s products are used in over 1,000 schools and can be purchased at over 10,000 retail
BlueTalon has closed a USD16 million Series A financing round led by Maverick Ventures, with participation from new investor Arsenal Venture Partners and existing investors Signia Venture Partners, Data Collective, Divergent Ventures, Bloomberg Beta and Stanford-StartX Fund.
The new funding will be used for continued expansion of BlueTalon’s development and sales teams to address the increasing demand for BlueTalon’s data-centric security solutions.
Matthew Kinsella, managing director at Maverick Ventures, has joined the BlueTalon board of directors.
To date, BlueTalon has raised over USD25 million in funding.
By unifying security policies across multiple data platforms, BlueTalon
Funds managed by Alpina Partners have acquired Cimdata from Infoniqa Holding and iLab24.
Cimdata will now become part of a larger group of enterprise software businesses focusing on enterprise resource planning (ERP).
Alpina has previously acquired a majority stake in Oxaion, an ERP software company based in Ettlingen, Germany.
Terms of the transaction have not been disclosed.
“We are happy to welcome Cimdata as new member of our software buy-and-build platform. The company is a well-respected supplier of specialised ERP software solutions with a clear focus on the manufacturing industry,” says Florian Strehle, partner at Alpina Partners.
Ipreo, a provider of market intelligence and workflow solutions to public issuers, sell-side firms and buy-side investors, is launching a new private company solutions (PCS) solution, Prism.
Ipreo says Prism will build on the firm’s existing expertise in capital raising and shareholder management to private companies, which face unprecedented challenges amidst the ever-increasing complexity of today's capital markets.
Ipreo says the Prism value proposition is squarely aligned to the pain points felt by thousands of private companies.
It is a holistic, cloud-based, CFO-desktop that equips private companies to manage regulatory requirements, securely communicate with shareholders, execute liquidity events
Guernsey Finance – the promotional agency for the island’s finance industry internationally – has launched a new corporate brand and logo, We Are Guernsey.
The rebranding follows lengthy consultation with local industry focus groups.
The new brand and logo will now be used to promote the jurisdiction overseas in place of the old Guernsey International Finance Centre branding.
Guernsey Finance chief executive Dominic Wheatley says the new brand provides Guernsey with a fresh and current look that is fit for the modern world.
“It goes without saying that Guernsey is an international finance centre, so we wanted
Gordian Compliance Solutions, a boutique consulting firm specialising in regulatory compliance services for financial industry firms, has promoted four employees to managing partner positions.
Each of the new partners – Ben Buckwalter, Patrick Dominguez, Yulia Kalk and Justin Schleifer – has been with the firm for more than three years and has been instrumental in its growth.
Buckwalter serves as general counsel for both Gordian Compliance Solutions and affiliate, Gordian Investments, a FINRA member broker-dealer. Buckwalter also serves as senior compliance consultant to the firm’s investment adviser clients.
Dominguez serves as the director of investment adviser services for
Yukon Partners, a provider of mezzanine capital for middle market private equity transactions, has partnered with Revelstoke Capital Partners in its investment in Fast Pace Urgent Care.
Fast Pace Urgent Care, headquartered in Brentwood, Tennessee, is a regional manager of urgent care clinics across rural Tennessee and Kentucky.
The company’s nurse practitioner model with physician oversight increases rural patient access to healthcare. Due to the rural focus of the company’s current operations, many of the patients use the company’s urgent care clinics as their primary care solution allowing the company to function as an integral healthcare provider in the
BioLineRx, a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing new drugs, has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing new therapies.
The joint venture, named iPharma, will develop clinical and pre-clinical therapeutic candidates originating primarily in Israel to serve the Chinese and global healthcare markets.
Under the terms of the JV agreement, each partner will provide seed capital of one million dollars to the venture. BioLineRx will screen and identify promising early-stage drug candidates originating primarily in Israel with emphasis on therapeutic indications that are of special
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
